Cyteir Therapeutics Inc Research and Development (R&D) Expense Ratio is NA for the quarter ending September 30, 2023. The RD expense ratio measures the proportion of a company's research and development (R&D) expenses to its revenue. It is calculated by dividing the R&D expenses by the revenue. This ratio indicates the level of investment in R&D relative to the company's revenue generation. A higher ratio suggests a greater allocation of resources towards research and development activities, indicating a focus on innovation and potential future growth.